OUR TEAM

Elham F. Steiner

Counsel

Madison, NJ
One Giralda Farms
Madison, NJ 07940
P 973.966.3296 F 973.966.3250
 P 973.966.3296 F 973.966.3250
EMAIL   |   DOWNLOAD VCARD

Experience

Ellie Steiner is a seasoned lawyer specializing in patent litigation. She has been litigating high-stakes intellectual property disputes for over 20 years with a particular focus on district court litigation and Federal Circuit appeals. Ellie also works on matters before the Patent Trial and Appeal Board (PTAB) and the International Trade Commission (ITC). She has a broad range of experience, representing clients in matters related to biologic and small-molecule drugs, medical devices, drug delivery systems, software, and semiconductors.

Ellie leads litigation teams in all aspects of complex patent litigation, including pre-litigation strategy, pre-trial and expert discovery, trial, and appeals. She is instrumental in formulating case strategy, preparing briefs, handling oral argument and Markman proceedings, and examining witnesses at trial. Ellie has led teams in obtaining favorable judgments and settlements in district courts and inter partes review proceedings.

In addition to patent litigation, Ellie counsels clients on a wide range of intellectual property licensing issues, including drafting and negotiating patent licenses. She frequently works with life science clients to create strategies based on her extensive knowledge of the regulatory landscape. Ellie has also litigated a number of trademark and copyright cases.

Representative Experience

  • Secured Federal Circuit victories for Viatris (formerly Mylan) on appeals affirming PTAB decisions invalidating several Sanofi patents related to Sanofi’s Lantus and Lantus SoloSTAR insulin glargine products, paving the way for Viatris to commercialize Semglee, the first approved interchangeable biologic.
  • Secured trial verdict of non-infringement and invalidity in favor of Viatris (formerly Mylan) on Sanofi’s patent for an injector pen for delivering insulin.
  • Secured a victory for Viatris (formerly Mylan) in IPR proceedings at the PTAB, clearing a significant hurdle towards the marketing of Viatris’ proposed 2.5 mg rivaroxaban tablets.
  • Represented Mylan Pharmaceuticals in breach of contract and patent infringement dispute arising from Mylan’s launch of its generic colchicine product.
  • Successfully served as counsel for generic pharmaceutical companies in Hatch-Waxman Act litigation relating to the following pharmaceutical products: Uptravi (selexipag), Xarelto (rivaroxaban), Pomalyst (pomalidomide), Revlimid (lenalidomide), Suboxone (buprenorphine/naloxone sublingual film), Pradaxa (dabigatran), Minivelle (estradiol transdermal patch), Zometa (zoledronic acid infusion), Reclast (zoledronic acid infusion), Daytrana (methylphenidate transdermal patch), Velcade (bortezomib), Uloric (febuxostat), Lexiva (fosamprenavir), Actoplus Met XR (pioglitazone/metformin), Celebrex (celecoxib), and Nuvigil (armodafinil).
  • Represented Azurity Pharmaceuticals in patent litigations relating to Azurity’s Nymalize product.
  • Represented Edwards Lifesciences in patent infringement litigation involving mitral and aortic valve holders and intra-aortic filters.
  • Represented LSI at the International Trade Commission against twenty-three respondents relating to semiconductor integrated circuits.
  • Represented Amazon.com, A9.com, and Alexa Internet against claims that search engine capabilities rendered them liable for copyright infringement.
  • Represented Area 55 in patent litigation involving wine aeration.
  • Represented MEEI in patent infringement dispute involving treatment of age-related macular degeneration.
  • Represented Praxair in patent litigation involving gas delivery systems for semiconductor fabrication.

Recognition

Ellie has been recognized by the Daily Journal as a Top Intellectual Property Lawyer and as one of the best performing ANDA attorneys representing defendants in Patexia's ANDA Litigation Intelligence Report.

Practices

Education

  • J.D., Duke University School of Law
  • B.S., Molecular Biology, University of California, San Diego

Admissions

  • California
  • New York
  • United States Supreme Court
  • United States Court of Appeals for the Federal Circuit
  • United States District Court for the Northern District of California
  • United States District Court for the Eastern District of California
  • United States District Court for the Central District of California
  • United States District Court for the Southern District of California
  • United States District Court for the Southern District of New York
  • United States District Court for the Eastern District of New York